IP Library › Granted Patent US 12,547,090
Granted Patent B2
US 12,547,090 · App. 17/659,084 · Granted Feb 10, 2026

Toner

Inventors: Kouichirou Ochi (Chiba, JP); Masayuki Hama (Ibaraki, JP); Hayato Ida (Ibaraki, JP); Yuya Chimoto (Chiba, JP); Hisasuke Kajihara (Ibaraki, JP)
Assignee: CANON KABUSHIKI KAISHA
G03G9/09716G03G9/0819G03G9/08711
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,547,090
App. No.
17/659,084
Granted
Feb 10, 2026
Kind
B2
Abstract

A toner comprising a toner particle comprising a colorant, a binder resin, and calcium carbonate particles, wherein an amount of the colorant in the toner particle is from 1.0 to 20.0% by mass; the binder resin comprises a polyester resin; the polyester resin has an aromatic ring concentration of from 50 to 70 mol %; a surface of the calcium carbonate particles is coated with a fatty acid; an amount of the calcium carbonate particles in the toner particle is from 1.0 to 15.0% by mass; a number average particle diameter of the calcium carbonate particles is from 150 nm to 800 nm.

Claims (22)

1 . A toner, comprising:

a toner particle comprising a colorant, a binder resin and calcium carbonate particles;

the binder resin comprising a polyester resin having an aromatic ring concentration of 55 to 70 mol % when aromatic ring concentration (mol %)=(number of moles of carbon constituting aromatic rings)/(total number of moles of carbon)×100;

the polyester resin being a condensate of a polyhydric alcohol compound and a polyvalent carboxylic acid compound;

the polyvalent carboxylic acid compound comprising a terephthalic acid; and

a surface of the calcium carbonate particles being coated with a fatty acid, wherein

a content ratio of the polyester resin in the toner particle is 45 to 80% by mass,

the calcium carbonate particles have a number average particle diameter of 150 to 800 nm,

an amount of colorant in the toner particle is 1.0 to 20.0% by mass,

an amount of calcium carbonate particles in the toner particle is 2.5 to 10.0% by mass, and

A/B is 0.8 to 2.5, where A (% by mass) is the amount of colorant in a toner particle and B (% by mass) is the amount of calcium carbonate particles in the toner particle.

2 . The toner according to claim 1 , wherein the amount of colorant in the toner particle is 1.0 to 10.0% by mass.

3 . The toner according to claim 1 , wherein the binder resin comprises a resin having a polystyrene skeleton.

4 . The toner according to claim 3 , wherein an amount of resin having the polystyrene skeleton in the toner particle is 0.3 to 25% by mass.

5 . The toner according to claim 3 , wherein the resin having the polystyrene skeleton is a styrene-acrylic acid ester copolymer.

6 . The toner according to claim 1 , wherein the aromatic ring concentration of the polyester resin is 55 to 60 mol %.

7 . The toner according to claim 1 , wherein an amount of the fatty acid coated on the calcium carbonate particles is 0.1 to 5.0% by mass.

8 . The toner according to claim 1 , wherein the fatty acid is a linear saturated fatty acid having 8 to 28 carbon atoms.

9 . The toner according to claim 1 , wherein the fatty acid is stearic acid.

10 . The toner according to claim 1 , wherein the colorant comprises a pigment having an SP value of 8.0 to 10.0 (cal/cm 3 ) (1/2) .

11 . The toner according to claim 1 , wherein the colorant comprises at least one member selected from the group consisting of a magenta pigment, a cyan pigment and a yellow pigment.

12 . The toner according to claim 1 , wherein the polyhydric alcohol compound comprises an alkylene oxide adduct of bisphenol A.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2022
From: OCHI, KOUICHIROU; HAMA, MASAYUKI; IDA, HAYATO; CHIMOTO, YUYA; KAJIHARA, HISASUKE
To: CANON KABUSHIKI KAISHA
Reel/Frame 059887/0250 →
Priority Claims (2)
JP 2021-073404 · Apr 23, 2021 · national
JP 2022-006121 · Jan 19, 2022 · national
Continuity (1)
Related Publication 20220342335A1 · Oct 27, 2022
References Cited (83)
US 6430384B2 · Hama et al. · 2002 [cited by applicant]
US 7135263B2 · Kawakami et al. · 2006 [cited by applicant]
US 7833687B2 · Kato et al. · 2010 [cited by applicant]
US 8697327B2 · Shibata et al. · 2014 [cited by applicant]
US 8921023B2 · Baba et al. · 2014 [cited by applicant]
US 8927188B2 · Naka et al. · 2015 [cited by applicant]
US 9057970B2 · Ida et al. · 2015 [cited by applicant]
US 9348247B2 · Ida et al. · 2016 [cited by applicant]
US 9348253B2 · Kanno et al. · 2016 [cited by applicant]
US 9448501B2 · Inoue et al. · 2016 [cited by applicant]
US 9540483B2 · Ida et al. · 2017 [cited by applicant]
US 9651883B2 · Hama et al. · 2017 [cited by applicant]
US 9665023B2 · Kamae et al. · 2017 [cited by applicant]
US 9696644B2 · Ida et al. · 2017 [cited by applicant]
US 9897934B2 · Tamura et al. · 2018 [cited by applicant]
US 10012920B2 · Shibata et al. · 2018 [cited by applicant]
US 10036970B2 · Kanno et al. · 2018 [cited by applicant]
US 10078281B2 · Ida et al. · 2018 [cited by applicant]
US 10082743B2 · Hama et al. · 2018 [cited by applicant]
US 10088765B2 · Miyakai et al. · 2018 [cited by applicant]
US 10146146B2 · Komatsu et al. · 2018 [cited by applicant]
US 10175595B2 · Onozaki et al. · 2019 [cited by applicant]
US 10197936B2 · Onozaki et al. · 2019 [cited by applicant]
US 10203619B2 · Yamashita et al. · 2019 [cited by applicant]
US 10228629B2 · Tamura et al. · 2019 [cited by applicant]
US 10274851B2 · Hashimoto et al. · 2019 [cited by applicant]
US 10353312B2 · Kamae et al. · 2019 [cited by applicant]
US 10401748B2 · Hashimoto et al. · 2019 [cited by applicant]
US 10423086B2 · Hama et al. · 2019 [cited by applicant]
US 10451986B2 · Sano et al. · 2019 [cited by applicant]
US 10451990B2 · Kamae et al. · 2019 [cited by applicant]
US 10474049B2 · Onozaki et al. · 2019 [cited by applicant]
US 10514624B2 · Tamura et al. · 2019 [cited by applicant]
US 10564560B2 · Onozaki et al. · 2020 [cited by applicant]
US 10599060B2 · Kanno et al. · 2020 [cited by applicant]
US 10656545B2 · Kamae et al. · 2020 [cited by applicant]
US 10775710B1 · Kamae et al. · 2020 [cited by applicant]
US 10859931B2 · Hashimoto et al. · 2020 [cited by applicant]
US 10877386B2 · Murayama et al. · 2020 [cited by applicant]
US 10969705B2 · Shirayama et al. · 2021 [cited by applicant]
US 11029617B2 · Chimoto et al. · 2021 [cited by applicant]
US 11112711B2 · Ochi et al. · 2021 [cited by applicant]
US 11131939B2 · Hama et al. · 2021 [cited by applicant]
US 11181848B2 · Ochi et al. · 2021 [cited by applicant]
US 20130108955A1 · Shibata et al. · 2013 [cited by applicant]
US 20140128529A1 · Sakai · 2014 [cited by examiner]
US 20140134535A1 · Baba et al. · 2014 [cited by applicant]
US 20150099227A1 · Ida et al. · 2015 [cited by applicant]
US 20170082933A1 · Dan · 2017 [cited by applicant]
US 20180314176A1 · Ikeda et al. · 2018 [cited by applicant]
US 20200310273A1 · Chimoto et al. · 2020 [cited by applicant]
US 20200409284A1 · Matsubara et al. · 2020 [cited by applicant]
US 20200409285A1 · Tokunaga et al. · 2020 [cited by applicant]
US 20210080848A1 · Tsuchida et al. · 2021 [cited by applicant]
US 20210141315A1 · Kamae et al. · 2021 [cited by applicant]
US 20210181647A1 · Hashimoto et al. · 2021 [cited by applicant]
US 20210181649A1 · Kanno et al. · 2021 [cited by applicant]
US 20210181650A1 · Hama et al. · 2021 [cited by applicant]
US 20210181651A1 · Kanno et al. · 2021 [cited by applicant]
US 20210278774A1 · Hashimoto et al. · 2021 [cited by applicant]
US 20210278775A1 · Kamae et al. · 2021 [cited by applicant]
US 20220187728A1 · Miura et al. · 2022 [cited by applicant]
US 20220197163A1 · Kajihara et al. · 2022 [cited by applicant]
US 20220197166A1 · Chimoto et al. · 2022 [cited by applicant]
US 20220197174A1 · Kajihara et al. · 2022 [cited by applicant]
JP 8339095A · 1996 [cited by applicant]
JP 200599422A · 2005 [cited by applicant]
JP 2013200559A · 2013 [cited by applicant]
JP 2015194667A · 2015 [cited by applicant]
JP 201699517A · 2016 [cited by applicant]
JP 2016114828A · 2016 [cited by applicant]
JP 20173901A · 2017 [cited by applicant]
JP 2019211505A · 2019 [cited by applicant]
JP 2021182045A · 2021 [cited by applicant]
WO WO2015141321A1 · 2015 [cited by examiner]
U.S. Appl. No. 17/648,330, Hiroki Watanabe, filed Jan. 19, 2022, [cited by applicant]
U.S. Appl. No. 17/648,333, Ichiro Kanno, filed Jan. 19, 2022. [cited by applicant]
U.S. Appl. No. 17/648,368, Ichiro Kanno, filed Jan. 19, 2022. [cited by applicant]
U.S. Appl. No. 17/654,461, Yukihiro Abe, filed Mar. 11, 2022. [cited by applicant]
U.S. Appl. No. 17/654,481, Kazuki Murata, filed Mar. 11, 2022. [cited by applicant]
U.S. Appl. No. 17/656,282, Takeshi Hashimoto, filed Mar. 24, 2022. [cited by applicant]
U.S. Appl. No. 17/663,935, Miki Ueda, filed May 18, 2022. [cited by applicant]
U.S. Appl. No. 17/664,102, Megumi Shino, filed May 19, 2022. [cited by applicant]
Cited By (1)
US 12,631,980